- Home
- ML vs EYPT Comparison
ML vs EYPT Comparison
Compare ML & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ML
- EYPT
- Stock Information
- Founded
- ML 2013
- EYPT 1987
- Country
- ML United States
- EYPT United States
- Employees
- ML N/A
- EYPT N/A
- Industry
- ML Retail: Computer Software & Peripheral Equipment
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- ML Technology
- EYPT Industrials
- Exchange
- ML Nasdaq
- EYPT Nasdaq
- Market Cap
- ML 482.3M
- EYPT 439.4M
- IPO Year
- ML N/A
- EYPT 2005
- Fundamental
- Price
- ML $78.89
- EYPT $9.17
- Analyst Decision
- ML Strong Buy
- EYPT Strong Buy
- Analyst Count
- ML 7
- EYPT 8
- Target Price
- ML $96.17
- EYPT $27.29
- AVG Volume (30 Days)
- ML 249.5K
- EYPT 1.1M
- Earning Date
- ML 11-07-2024
- EYPT 11-07-2024
- Dividend Yield
- ML N/A
- EYPT N/A
- EPS Growth
- ML N/A
- EYPT N/A
- EPS
- ML 0.28
- EYPT N/A
- Revenue
- ML $500,281,000.00
- EYPT $45,713,000.00
- Revenue This Year
- ML $29.31
- EYPT N/A
- Revenue Next Year
- ML $21.37
- EYPT N/A
- P/E Ratio
- ML $286.93
- EYPT N/A
- Revenue Growth
- ML 23.40
- EYPT 7.50
- 52 Week Low
- ML $31.42
- EYPT $5.86
- 52 Week High
- ML $106.82
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- ML 74.50
- EYPT 38.25
- Support Level
- ML $44.23
- EYPT $11.26
- Resistance Level
- ML $90.55
- EYPT $12.23
- Average True Range (ATR)
- ML 5.73
- EYPT 0.97
- MACD
- ML 3.22
- EYPT -0.30
- Stochastic Oscillator
- ML 75.93
- EYPT 3.24
About ML MoneyLion Inc.
MoneyLion Inc is a mobile banking and financial membership platform that empowers people to take control of their finances. It is a full-service digital platform to deliver mobile banking, lending, and investment solutions. The company offers a personalized, all-in-one, digital financial platform that provides convenient, low-cost access to banking, borrowing, and investing solutions tailored for its customers, rooted in data, and delivered through its proprietary technology platform.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.